Skip to content

Effect of storage age of transfused platelet concentrates on platelet increment in critically ill patients.

Effect of storage age of transfused platelet concentrates on platelet increment in critically ill patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050676
Enrollment
74
Registered
2023-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D691- Qualitative platelet defects

Interventions

Intervention1: Group 1 - Fresh platelets Group 2 - day 4-5 platelets: Group 1- Patients will be transfused platelet concentrates less than or equal to 3 days Group 2- Patients will be transfused pla

Sponsors

GMCH Sector 32
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to multidisciplinary ICU and requiring platelet transfusion. Age more than 18 years. Expected duration of ICU stay more than 24 hours. No platelet transfusion within 24 hours prior to ICU admission.

Exclusion criteria

Exclusion criteria: Patients with active bleeding or known bleeding disorder. Patients receiving out of group ABO compatible platelet transfusion. Patients receiving less than adult platelet dose. Patients with RhD negative blood groups. Patients with sepsis on admission. Patients with previous platelet transfusion within 24 hours.

Design outcomes

Primary

MeasureTime frame
Corrected count increment and percentage platelet recovery in both the study arms Timepoint: Post transfusion platelet count will be measured at 10 minutes to 1 hour and 18-24 hours after transfusion of at least four random donor platelet concentrates or one single donor platelet concentrate.

Secondary

MeasureTime frame
Length of stay in ICU, clinical bleeding WHO grade 2 or more, need for red cell transfusion, incidence of infections, adverse transfusion reactions and mortality.Timepoint: Length of stay in ICU, clinical bleeding WHO grade 2 or more, need for red cell transfusion, incidence of infections, adverse transfusion reactions and mortality.

Countries

India

Contacts

Public ContactPARAMJIT KAUR

Government Medical College and Hospital, Chandigarh

paramjit.gp71@yahoo.com9646121583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026